| Sarah Jane Speck, | |
|
801 E Sioux Ave, Pierre, SD 57501-3323 | |
| (605) 224-3100 | |
| Not Available |
| Full Name | Sarah Jane Speck |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 801 E Sioux Ave, Pierre, South Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124784103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | CP002209 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Mary's Hospital | Pierre, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera St Marys | 0143134965 | 84 |
News Archive
In an unprecedented scale, researchers have begun to unravel the genetics that may predispose some individuals to develop kidney disease once they have diabetes, independent of the degree of blood sugar control.
The microbes living in a baby's gut during its first month of life may directly impact the developing immune system, leading to a higher risk of allergies and asthma later in childhood, according to a study by researchers at UC San Francisco and the Henry Ford Health System in Detroit.
The U.S. Food and Drug Administration has approved a stent for use in opening blocked arteries in the neck. The new stent is intended to prevent stroke by treating blockages in the carotid artery, the main blood vessel leading to the brain.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
› Verified 8 days ago
| Entity Name | Avera St Marys |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669457180 PECOS PAC ID: 0143134965 Enrollment ID: O20040225000579 |
News Archive
In an unprecedented scale, researchers have begun to unravel the genetics that may predispose some individuals to develop kidney disease once they have diabetes, independent of the degree of blood sugar control.
The microbes living in a baby's gut during its first month of life may directly impact the developing immune system, leading to a higher risk of allergies and asthma later in childhood, according to a study by researchers at UC San Francisco and the Henry Ford Health System in Detroit.
The U.S. Food and Drug Administration has approved a stent for use in opening blocked arteries in the neck. The new stent is intended to prevent stroke by treating blockages in the carotid artery, the main blood vessel leading to the brain.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Jane Speck, 801 E Sioux Ave, Pierre, SD 57501-3323 Ph: (605) 224-3100 | Sarah Jane Speck, 801 E Sioux Ave, Pierre, SD 57501-3323 Ph: (605) 224-3100 |
News Archive
In an unprecedented scale, researchers have begun to unravel the genetics that may predispose some individuals to develop kidney disease once they have diabetes, independent of the degree of blood sugar control.
The microbes living in a baby's gut during its first month of life may directly impact the developing immune system, leading to a higher risk of allergies and asthma later in childhood, according to a study by researchers at UC San Francisco and the Henry Ford Health System in Detroit.
The U.S. Food and Drug Administration has approved a stent for use in opening blocked arteries in the neck. The new stent is intended to prevent stroke by treating blockages in the carotid artery, the main blood vessel leading to the brain.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital
› Verified 8 days ago
Danielle Campbell, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Mac Ln, Pierre, SD 57501 Phone: 605-224-5901 | |
Julie Ann Cox, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Mac Ln, Pierre, SD 57501 Phone: 605-224-5901 | |
Ericka Leslie Petersen, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Mac Ln, Pierre, SD 57501 Phone: 605-224-5901 | |
Ms. Tami Lynn Hogie-lorenzen, CNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1714 Abbey Road, Pierre, SD 57501 Phone: 605-224-8841 Fax: 605-224-6852 | |
Mrs. Kimberly Haines, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 640 E Sioux Ave, Pierre, SD 57501 Phone: 605-945-5560 | |
Wren Hollingsworth, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Mac Ln, Pierre, SD 57501 Phone: 605-224-5901 |